Amplification in tumors and benign tissue of breast cancer patients

Cancer Letters

Volumn 107, Issue 2, 1996, Pages 235-239

  Yazici, Hülya ^a   Müslümanoǧlu, Mahmut ^b   Güzey, Deniz ^c   Yasasever, Vildan ^a   Özbek, Uǧur ^a   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c VAKIF GUREBA HOSPITAL   (Turkey)

Author keywords

Amplification; Breast cancer; Erb B2 gene

Indexed keywords

ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE NUMBER; HUMAN; HUMAN TISSUE; ONCOGENE C ERB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE GENETICS;

EID: 0030598165     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04365-0     Document Type: Article

References (36)

1. [1] Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A. and Press, M.F. (1989) Studies of the Her-2/neu protooncogene in human breast and ovarian cancer, Science, 244, 707-712.
2. [2] Perren, T.J. (1991) c-erb B2 oncogene as a prognostic marker in breast cancer, Cancer, 63, 328-332.
3. [3] Bianchi, S., Paglierani, M., Zampi, G., Cardona, G., Cataliotti, L., Bonardi, R. and Ciatto, S. (1993) Prognostic significance of c-erb B2 expression in node negative breast cancer, Br. J. Cancer, 67, 625-629.
4. [4] Yasasever, V., Karaloǧlu, D., Yazici, H., Olgaç, V. and Dalay, N. (1993) Cancer associated marker proteins in the tumor and benign tissue of breast cancer patients, J. Tumor Marker Oncol., 8, 33-38.
5. [5] Yasasever, V., Karaloǧlu, D., Yazici, H., Onat, H. and Dalay, N. (1992) Serum neu oncoprotein levels as a tumor marker in breast cancer, J. Tumor Marker Oncol., 7, 33-42.
6. [6] Ciocca, D.R., Fujimura, F.K., Tandon, A.K., Clark, G.M., Mark, C., Lee, Chen, G.J., Pounds, Vandely, P., Owens, M.A., Pandian, M.R. and McGuire, W.I. (1992) Correlation of Her-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J. Natl. Cancer Inst., 84, 1272-1282.
7. [7] Toikkanen, S., Helin, H., Isola, J. and Joensuu, H. (1992) Prognostic significance of Her-2 oncoprotein expression in breast cancer. A 30 year follow up, J. Clin. Oncol., 10, 1044-1048.
8. [8] Meden, H., Marx, D., Fattahi, A., Rath, W., Kron, M., Wuttke, W., Schauer, A. and Kuhn, W. (1994) Elevated serum levels of a c-erb B2 oncogene product in ovarian cancer patients and in pregnancy, J. Cancer Res. Clin. Oncol., 120, 378-381.
9. [9] Anderson, I.J. (1992) c-erb B2 oncogene in breast cancer: the right target or a decoy?, Hum. Pathol., 23, 971-973.
10. [10] Borg, A., Tandon, A.K., Sigurdsson, H., Clark, G.M., Ferno, M., Fuqua, S.A.W., Killander, D. and McGuire, W.L. (1990) Her-2/neu amplification predicts poor survival in node positive breast cancer, Cancer Res., 50, 4332-4337.
11. [11] Merkel, D.E. (1992) Prognostic markers in early breast cancer, Contemp. Oncol., 2, 53-60.
12. [12] Paterson, M.C., Dietrich, K.D., Danyluk, J., Paterson, A.H.G., Less, A.W. and Jamil, N. (1991) Correlation between c-erb B2 amplification and risk of recurrence in node negative breast cancer, Cancer Res., 51, 556-567.
13. [13] Seshadri, R., Firgaira, F.A., Horsfall, D.J., McCaul, K., Setlur, V. and Kitchen, P. (1993) Clinical significance of Her-2/neu oncogene amplification in primary breast cancer, J. Clin. Oncol., 11, 1936-1942.
14. [14] Paterson, M.C., Dietrich, K.D., Danyluk, A., Paterson, H.G., Lees, A.W., Jamil, N., Hanson, J., Jenkins, H., Krause, B.E., McBlain, W.A.M., Slamon, D.J. and Fourney, R.M. (1991) Correlation between c-erb B2 amplification and risk of recurrent disease in node negative breast cancer, Cancer Res., 51, 556-567.
15. [15] Kynask, B., Binderk, L., Marx, D., Zoll, B., Schmoll, H.J., Oellerich, M. and Schauer, A. (1993) Determination of a fragment of the c-erb B 2 translational product p185 in serum of breast cancer patients, J. Cancer Res. Clin. Oncol., 119, 249-252.
16. [16] Gullick, W.J., Love, S.B., Wright, C., Barner, D.M., Gusterson, B., Harris, A.L. and Altman, D.G. (1991) c-erb B2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes, Br. J. Cancer, 63, 434-438.
17. [17] Lovekin, C., Ellis, I.O., Locker, A., Robertson, J.F.R., Bell, J., Nicholson, R., Gullick, W.J., Elston, C.W. and Blamey, R.W. (1991) c-erb B2 oncoprotein expression in primary and advanced breast cancer, Br. J. Cancer, 63, 439-443.
18. [18] Gusterson, B.A., Gelber, R.D., Goldhirsch, K.N., Price, K.N., Save-Söderborgh, J., Anbazhagon, R., Styles, J., Rudenstam, C.M., Golough, R., Reed, R., Martinez-Tello, F., Tiltman, A., Torhorsk, P., Grigolato, R., Bettelheim, R., Nevilla, A.M., Burki, K., Castiglione, M., Collins, J., Lindther, J. and Senn, H.J. (1992) Prognostic significance of c-erb B2 expression in breast cancer, J. Clin. Oncol., 10, 1049-1056.
19. [19] Ali, I.U., Campbell, G., Liderau, R. and Collahan, R. (1988) Amplification of c-erb B2 and aggressive human breast tumors?, Science, 240, 1795-1798.
20. [20] Tandon, A.K., Clark, G.M., Chamness, G.C., Ullrich, A. and McGuire, W.L. (1989) Her-2/neu oncogene protein and prognosis in breast cancer, J. Clin. Oncol., 7, 1120-1128.
21. [21] Nagayama, K. and Watatani, M. (1993) Analysis of genetic alterations related to the development and progression of breast carcinoma, Jpn. J. Cancer Res., 84, 1159-1164.
22. [22] Parker, H.C., Lilycrop, K., Howell, A. and Craig, R.K. (1990) c-erb B2 mRNA expression in human breast tumors. Comparison with c-erb B2 DNA amplification and correlation with prognosis, Br. J. Cancer, 61, 39-45.
23. [23] Borg, A., Baldetorg, B., Ferno, M., Olsson, H. and Sigurdsson, H. (1991) erb B2 amplification in breast cancer with a high rate of proliferation, Oncogene, 6, 137-143.
24. [24] Lönn, U., Lönn, S., Nilsson, B. and Stenkvisk, B. (1995) Prognostic value of erb B2 and myc amplification in breast cancer, Imprints Cancer, 75, 2681-2687.
25. [25] Maniatis, T., Fritsch, E.F. and Sambrook, J. (1990) Molecular Cloning. A Manual, pp. 545. Editors: T. Maniatis, E.F. Fritsch and J. Sambrook. Cold Spring Harbor Laboratory Press, New York.
26. [26] Galen, R.S. and Gambino, S.R. (1975) The Predictive Value and Efficiency of Medical Diagnoses. Wiley, New York.
27. [27] Parker, H.C., Lilycrop, K., Howell, A. and Craig, R.K. (1990) c-erb B2 mRNA expression in human breast tumors. Comparison with c-erb B2 DNA amplification and correlation with poor prognosis, Br. J. Cancer, 61, 39-45.
28. [28] Sestini, R., Orlando, C., Zentilin, L., Gelmini, S., Pinzani, P., Bianchi, S., Selli, C., Giacca, M. and Pazzagli, M. (1994) Measuring c-erb B2 oncogene amplification in fresh and paraffin embedded tumors by competitive polymerase chain reaction, Clin. Chem., 40, 630-636.
29. [29] Sieberk, P.D. and Larrik, J.W.(1992) Competitive PCR. Nature, 359, 557-558.
30. [30] Diviacco, S., Norio, P., Zentilin, L., Menzo, S., Clementi, M. and Biamonti, O. (1992) A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates, Gene, 122, 1013-1020.
31. [31] Friedricks, K., Lohmann, D. and Höfler, H. (1993) Detection of Her-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections, Virchow Arch. B., 64, 209-212.
32. [32] Bacus, S.S., Bacus, J.W., Slamon, D.J. and Press, M.F. (1990) Her-2/neu oncogene expression and DNA ploidy analysis in breast cancer, Arch. Pathol. Lab. Med., 114, 164-169.
33. [33] Li, B.D.L., Harlow, S.P., Budnick, R.M., Sheedy, D.L. and Stewart, C.C. (1994) Detection of Her-2/neu oncogene amplification in flow cytometry sorted breast ductal cells by competitive polymerase chain reaction, Cancer, 73, 2771-2778.
34. [34] Elledge, R.M., Ciocca, D.R., Langone, G. and McGuire, W.L. (1993) Estrogen receptor, progesterone receptor and Her-2/ neu protein in breast cancer from pregnant patients, Cancer, 71, 2499-2506.
35. [35] Clark, G.M. and McGuire, W.L. (1991) Follow up study of Her-2/neu amplification in primary breast cancer, Cancer Res., 51, 944-948.
36. [36] Menard, S., Squicciarini, P., Luini, A., Sacchini, V., Rovini, D., Tagliabue, E., Veronesi, P., Salvadori, B., Veronesi, U. and Colaghi, M.I. (1991) Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumor prognostic features, Cancer Res., 51, 556-567.